about
Aspirin intake and survival after breast cancerMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldAlternative polyadenylation of cyclooxygenase-2.Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzymeThe selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in miceCaught in the cross fire: p53 in inflammation.COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivoNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityAntimetastatic activity of a cyclooxygenase-2 inhibitorPotential use of COX-2-aromatase inhibitor combinations in breast cancerDysregulation of integrin-linked kinase (ILK) signaling in colonic polyposisCOX-2 and cancer: a new approach to an old problemThe cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risksCyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancerInflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequencesCooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reductionPutting tumours in contextCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasThe growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasisFunctions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targetingGrowth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma.Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance.Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis.PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.Aspirin use and survival after diagnosis of colorectal cancerExpression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesionsTargeting the eicosanoid pathway in non-small-cell lung cancer.Fibroblast heterogeneity in the cancer wound.Calcium prevents tumorigenesis in a mouse model of colorectal cancerRole of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinomaThe COXes of Danio: from mechanistic model to experimental therapeutics.American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR.From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.Primary prevention of colorectal cancer.Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
P2860
Q24604280-415D5F50-6B24-4C31-B85D-8D1F407FEB3CQ24620628-AC0A7823-A4C6-490B-A771-B8806CF86256Q24798039-A96AD854-D281-4F48-B1D7-EBF3DABE44D2Q24798233-EF2EBB8C-3E22-42C1-9B03-390749B6631AQ25255790-948705AF-1BD2-4340-B2FA-9531F58B7528Q27692076-280C3EEB-C5DE-49B3-A4CA-9D3F3A4E43C0Q28165693-734ECDCE-8D37-4E18-95BF-16F1B8D2642AQ28166312-3BD4BEF2-60B8-48AD-84AA-898385ADF0F6Q28169082-E0193877-769C-4E6F-A130-476D4E03D336Q28187414-2070B130-492D-4E44-B3A0-F3B4C72A639FQ28189965-58952C7C-C290-403A-B68F-7C1B6AF49A26Q28191533-5E8EC699-1B42-48CB-B496-F7D00C40884CQ28193254-B3AF1D14-5269-47F9-96D9-FBFEED19BAE4Q28193375-FFE0E74C-5DA4-47BA-A067-FA28AF43B838Q28193430-4D1DD079-F92A-4EFD-B9CA-439F35335C61Q28196336-42ADAFF3-3C6F-41C8-8BB3-59ECF5E325CBQ28207789-547C4155-2C21-4803-BAF5-35E30B9E2FD9Q28293433-DA1D78FB-6686-49CB-83F3-559F1B0D3AD5Q28363021-E2588AEF-30CE-4E9D-8213-38E370F600D2Q28363575-F15833B8-D7B8-4767-A428-AB0319901138Q28363910-6B83E272-F10E-4143-BF15-6C55EF227A97Q28755868-334FF2A0-C052-479A-8849-764CC2F56F7AQ33183406-2EE3B417-87E3-439A-8F67-5DD0BD52A43CQ33437576-9C0E62BA-5A5C-4387-9EC0-7193585231C5Q33560977-88DE5D4D-D75B-4677-B8FA-6EC961EB60FBQ33665928-85B1CB13-3D08-4BF5-AC14-BA35B82B2120Q33675073-500B7E01-F102-497E-94E5-D33B63F915A9Q33752909-BC66190B-8490-4E7F-8130-E06C511C6E79Q33764480-5847525D-A770-43F9-BBB1-F06DF73481B0Q33868003-DAD16403-CE75-4EF1-9057-DDFE593CA130Q33936807-DC4EA703-B2DD-43B5-AEB3-3C4806A3463EQ33964324-791D9B64-F220-4582-A387-F8453B8E3D76Q33998926-13C02E2B-D52F-42C5-B9D5-F9A104AAF74FQ34021476-4A85D70C-B78D-4D75-BEEA-553E27FDE7FEQ34033369-34E51D51-4D0F-4004-8140-07A6D3E98FC1Q34070940-61514245-9EB2-4765-A3F3-D078E0479BBEQ34084150-DC92921C-33B8-414A-814D-CB789C6072CBQ34165145-60E45A6E-2197-4691-8860-E77C385B6852Q34182494-3A88CD8A-5A77-4800-8D6B-984A254F3936Q34234484-F3840FFC-6C21-4377-ABF4-4932EB7D57E9
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Host cyclooxygenase-2 modulates carcinoma growth.
@en
type
label
Host cyclooxygenase-2 modulates carcinoma growth.
@en
prefLabel
Host cyclooxygenase-2 modulates carcinoma growth.
@en
P2093
P2860
P356
P1476
Host cyclooxygenase-2 modulates carcinoma growth
@en
P2093
P2860
P304
P356
10.1172/JCI9621
P407
P577
2000-06-01T00:00:00Z